Spontaneous remission of eosinophilic granuloma of the maxilla after incisional biopsy: a case report
© The Author(s). 2016
Received: 13 December 2015
Accepted: 24 May 2016
Published: 2 June 2016
Langerhans cell histiocytosis (LCH), previously known as Histiocytosis X, is an infrequent disease that congregates a wide spectrum of clinical presentations with variable systemic involvement. Unification of these diseases under only one category is based on the almost identical histopathologic features of the lesions, but the etiology and proper approach for each presentation remains controversial. The localized alternative of Langerhans cell histiocytosis (LLCH), known as Eosinophilic Granuloma (EG) of bone, is the predominant clinical presentation of LCH. The maxilla is involved in 1 % of the head and neck region cases, representing an uncommon condition in this area.
In this clinical case report, it is described a case of a 16-year-old male patient with an asymptomatic osteolytic lesion at first upper left molar apical level, a finding detected on control radiographic images was reported as “Monostotic Eosinophilic granuloma of the maxillary bone”, which was later confirmed through an incisional biopsy. A surgical excision was initially planned, but finally it was not performed due to a spontaneous healing of the lesion after the incisional biopsy.
The presented case supports a conservative approach in the management of solitary EG of maxillary and mandibular bone lesions and even supports an expectant attitude in the course of treatment given the possibility of a spontaneous regression after the biopsy, especially in small lesions.
KeywordsLangerhans cell histiocytosis Eosinophilic Granuloma Maxillary bone
Lichtenstein and Jaffe introduced the term Histiocytosis X in 1953 to encompass a group of uncommon granulomatous proliferative disorders characterized by the presence of histiocytic cells [1, 2]. The Eosinophilic granuloma is traditionally considered as one of the three clinical manifestations of Histiocytosis X, which also includes Hand-Schuller-Christian and Letterer-Siwe diseases .
Later in 1985 the generic name of this diseases was changed to Langerhans Cell Histiocytosis (LCH), in recognition to the principal component of the proliferative cell population . As LCH is an uncommon disease, only a limited number of large surveys or randomized clinical trials are available in scientific literature and many treatment details remain either obscure or controversial [4, 5].
Only 1 % of the head and neck region cases of EG involves the maxillary bone . For this reason, the purpose of this case report is to describe a rare case of Eosinophilic Granuloma in a 16-year-old patient, which healed spontaneously after incisional biopsy, and to present a brief review of the available literature on the topic.
A 16-year-old male patient, without any relevant aspects in his medical history except a Non-Hodgkin lymphoma of his father, which is currently being treated, and a breast cancer of his mother, also in treatment. The patient was derived from the Hematology Unit for evaluation and definitive treatment of an osteolytic lesion in the left maxillary region with an evolution of nearly 2 months. Thirty days before, the patient had consulted at a dental service for a routine dental exam in which a radiolucent image appeared in the radiographic study. The patient underwent a biopsy of an asymptomatic osteolytic lesion located at apical level of the first upper left molar.
In his admission to our service, the oral and maxillofacial clinical examination did not show facial asymmetry, swelling or solution of continuity in the left maxillary alveolar ridge. The patient only had a slight and generalized gingival inflammation, and no other findings.
To complete the case study, additionally to the routine preoperative laboratory tests (blood count, biochemical profile and coagulation tests), a cone-beam CT (CBCT) was requested, and to rule out compromise of other bones, a scintigraphy was requested. Previously performed paraffin embedded samples of biopsy were also requested.
Langerhans cell histiocytosis is a group of disorders characterized for a clonal proliferation of Langerhans cells [2, 6], with a wide spectrum of clinical presentations, including solitary bone lesions with excellent prognosis, known as eosinophilic granuloma, and other systemic presentations with a multi-organic, disseminated and progressive course, previously known as Hand-Schüller-Christian syndrome and Letterer-Siwe disease . The current classification differentiates between single system disease with one organ or system involved and multisystem disease with two or more systems involved that may include ‘risk organs’ (hematopoietic system, spleen and/or liver) .
This grouping of different entities has been based on the similarities of the histopathologic appearance of the histiocytic and eosinophilic proliferation and by the involvement of Langerhans cells precursors . A presumptive diagnosis is made when the typical morphological features of Langerhans cells are found, and it is confirmed if it stains for S-100 protein, CD1a and/or CD207 (Langerin) antigens are positive . The detection of cytoplasmic inclusion bodies known as Birbeck-Breatnach granules is another typical characteristic of LCH . When the diagnosis is made, bone scan and PET are indicated to evaluate multiple involvements and to discard the possibility of polyostotic disease .
The cause and pathogenesis of these disorders remains unknown. It has been proposed that a basic immune defect may lead to proliferation of Langerhans cells; or that the Langerhans cell itself may carry a genetic defect leading to abnormal cellular proliferation . A key feature of this neoplasm is its clonal derivation from a single cell, which does not necessarily mean malignancy . On the other hand, it is reported that proinflammatory cytokines and chemokines as well as oncogenic B-type Raf kinase (BRAF) gene mutations are involved in the pathogenesis of EG . BRAF mutations are present in several malignant neoplasias including papillary thyrd carcinoma . Its finding in EG suggests a neoplastic condition of the lesion, concept that must be reevaluated considering the existence of spontaneous resolution of this disorder. Differentiation disorders of Langerhans cells have also been studied . Recently, it has been proposed a model of pathogenesis of Langerhans cell Histiocytosis in which there is an initial inflammatory condition potentiated by Interleukin 1, continued by mutations of BRAF genes. Both processes are also being considered as potential therapeutic targets .
Also, HCL has been associated with other malignancies such as leukemias, lymphomas and other solid tumors. This may precede, occur concurrently or follow the diagnosis of LCH and should be considered at every clinical visit [1, 4]. Acute lymphoblastic leukemia and lymphoma occur more often prior to the diagnosis of LCH, but they may be diagnosed up to 5 years after LCH .
In our case, the patient also has a family history of malignancies, although there is no clear family association for the development of these disorders, we must consider this precedence and assure clinical evaluations over time.
Clinical course and prognosis of the disease depend on the age of initial manifestation as well as the location and the organs involved . The anatomic site itself (particularly in bone involvement), the volume of involved soft tissue and local destruction degree have a greater impact on the outcome of the disease than the actual number of bones involved . Multisystem disease (MS-LCH) generally has a worse prognosis and a more complex treatment. Fortunately, EG is the predominant clinical form of LCH and accounts for 50 to 60 % of all cases of LCH . Any organ or system of the human body can be affected, but those more frequently involved are the skeleton (80 % of cases) and the skin (33 %) .
EG of bone is a disease with an incidence of one new case per 350,000 to 2 million per year [7, 8]. It is most common in teenagers and adults, with approximately 75 % of all patients younger than 20 years old [1, 8, 14] and 90 % under 40, with an average age of 19 . Males are affected twice as often as women . In the head and neck bone region, the compromised sites are skull (27 – 43 %), mandible (7 – 9 %), maxillary bone (1 %) and cervical vertebra (2 %), accordingly to the reported by Hicks J. et al., 2005 . Lesions are unifocal in 50 – 75 % of the cases, being 3 times more common than multifocal involvement . Our case report presents an interesting clinical case of a unifocal lesion of alveolar ridge of the maxillary bone, given its low incidence but especially for its spontaneous regression. Although literature reports spontaneous remission of EG in several locations including mandible, femur, intracranial bones, lungs and orbit bones [15–17]; no reference to a specific quantification of incidence was found. Several articles recommend considering the “wait and see” policy when this lesion is confirmed, but a closer and longer follow up appears to be strictly necessary.
The clinical spectrum of EG in maxillary and mandibular bones is quite varied and may mimic a variety of conditions, such as apical cysts, odontogenic tumors (e.g., ameloblastoma), non-odontogenic tumors (e.g., central giant cell granuloma), inflammatory diseases (e.g., osteomyelitis), vascular malformations, and malignancies [7, 14].
When there are clinical manifestations, the most common signs and symptoms in the oral cavity are intraoral mass, pain, gingival inflammation, bleeding, mobile teeth, oral mucosal ulcer, impaired healing, and halitosis [1, 7], and it is usually misdiagnosed as marginal periodontal infections . On the other hand, lesion may occasionally remain asymptomatic, leading to underdiagnosis . In our case the patient only referred localized swelling associated with gingival inflammation, with neither pain nor tooth mobility, and the lesion was detected with a routine panoramic radiography.
Due to incomplete understanding of the pathogenesis of LCH, treatment has been based on different empirical strategies, considering the extent of the disease and the severity at onset [4, 6]. There is also an agreement on the fact that single system disease has good prognosis with a high rate of spontaneous remission and negligible mortality . With unifocal bone disease, complete excision of bone lesions (curettage) may be indicated if the lesion is small (<2 cm) and for lesions with a diameter of 2 to 5 cm, a biopsy and curettage is an option [4, 19]. In the present case, surgical excision was proposed initially, but apparently simple curettage during the diagnostic biopsy turned out in remission at the control with CT scan. Consequently, it was decided to keep an expectant attitude, maintaining controls until the lesion’s total remission. This option is the most conservative and less invasive, and it is consistent with other cases presented previously, which support a conservative approach concerning treatment [2, 20, 21].
Another approach to solitary lesions treatment is an intra lesional injection of steroids [22–24], however, the standard treatment for LCH is not yet clear and surgery is still the treatment of choice in these cases [8, 14]. Other therapeutic combinations of LCH include surgery, chemotherapy and radiation, either individually or together, which may be necessary in multisystem disease. New therapeutic strategies are represented by monoclonal CD-1a-antibody-therapy and gene transfer into hemopoietic progenitor cells  and gene therapy .
Excision with or without radiation therapy has led to more than 95 % disease-free survival. However, relapse occurs in about 10 % of cases. Surgery alone has a 12 % recurrence rate, compared with 25 % for radiation therapy alone and 19 % for both combined therapies .
Patients without a histologically confirmed diagnosis need to be carefully monitored by appropriate imaging for at least 6 months after diagnosis in order to reassess the need for biopsy and its justification, in order to exclude a malignancy . In the present case, the patient has more than 1 year of postoperative controls. Besides, bone scintigraphy fortunately discards the possibility of polyostotic disease, which allowed us to maintain an expectant approach of the lesion’s regression, without the need of new surgery.
All patients should be followed for a sufficient time period, defined as (i) at least 5 years after the end of therapy; or (ii) 5 years after the last disease reactivation, in those who did not receive systemic therapy; or (iii) until final growth and pubertal development have occurred [4, 25]. In our case, since the pubertal growth of the patient is probably finished, a minimum of 5 years follow-up is necessary, to exclude recurrence.
Clinicians who treat maxillofacial disorders should be aware of the possibilities of LCH diagnosis and subsequent spectrum of clinical presentations. Faced with a diagnosis of HCL is mandatory to carry out a thorough examination and discard their participation in other systems.
The main lesson of this case report is the usefulness and validity of the use of conservative approaches in the management of EG solitary maxillary bone lesions and that it even supports an expectant attitude toward the possibility of spontaneous regression only performing biopsy, especially in small lesions.
CBCT, cone beam CT; CT, computed tomography; EG, cosinophilic Granuloma; LCH, lzangerhans cell histiocytosis; LLCH, localized langerhans cell histiocytosis; MS-LCH, lultisystem langerhans cell histiocytosis.
We thank Andrés Briner from IMAX, X-Ray Center, for his support with the radiological interpretation. We would also like to appreciate the assistance of Juan Andrés Papagno for language corrections.
PA and CF were responsible for writing the paper. PR performed a critical review of the paper in the oncology aspects. HR helped to draft the manuscript. BV contributed with the histological interpretation of the case. AV was responsible for writing, critical reviewing and performed the final revision of the article. All the authors read and approved the final manuscript.
The authors declare that no economical or personal factors exist which could result in a conflict of interests with respect to the published article. This article was done without external funding or other funding source.
Ethics approval and consent to participate
The authors declare that the patient has authorized the publication of the data included in this report; written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Hicks J, Flaitz CM. Langerhans cell histiocytosis: Current insights in a molecular age with emphasis on clinical oral and maxillofacial pathology practice. Oral Surgery Oral Med Oral Pathol Oral Radiol Endodontology. 2005;100(2 Suppl):42–66.Google Scholar
- Key SJ, O’Brien CJ, Silvester KC, Crean SJ. Eosinophilic granuloma: Resolution of maxillofacial bony lesions following minimal intervention. Report of three cases and a review of the literature. J Cranio Maxillofacial Surg. 2004;32(3):170–5.View ArticleGoogle Scholar
- DiCaprio MR, Roberts TT. Diagnosis and Management of Langerhans Cell Histiocytosis. J Am Acad Orthop Surg. 2014;22(10):643–52.View ArticlePubMedGoogle Scholar
- Haupt R, Minkov M, Astigarraga I, Schäfer E, Nanduri V, Jubran R, et al. Langerhans cell histiocytosis (LCH): Guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years. Pediatr Blood Cancer. 2013;60(2):175–84.View ArticlePubMedPubMed CentralGoogle Scholar
- Donadieu J, Chalard F, Jeziorski E. Medical management of langerhans cell histiocytosis from diagnosis to treatment. Expert Opin Pharmacother. 2012;13(9):1309–22.View ArticlePubMedGoogle Scholar
- Vaiselbuh SR, Bryceson YT, Allen CE, Whitlock JA, Abla O. Updates on histiocytic disorders. Pediatr Blood Cancer. 2014;61:1329–35.View ArticlePubMedGoogle Scholar
- Li Z, Li ZB, Zhang W, Li JR, Wang SP, Cheng Y, et al. Eosinophilic granuloma of the jaws: An analysis of clinical and radiographic presentation. Oral Oncol. 2006;42(6):574–80.View ArticlePubMedGoogle Scholar
- Eckardt A, Schultze A. Maxillofacial manifestations of Langerhans cell histiocytosis: A clinical and therapeutic analysis of 10 patients. Oral Oncol. 2003;39(7):687–94.View ArticlePubMedGoogle Scholar
- Park JW, Chung JW. Long-term treatment of Langerhans cell histiocytosis of the mandibular condyle with indomethacin. Oral Surg Oral Med Oral Pathol Oral Radiol Endod Elsevier Inc. 2010;109(4):e13–21.View ArticleGoogle Scholar
- Gonçalves CF, Morais MO, de Cássia Gonçalves Alencar R, Batista AC, Mendonça EF. Solitary langerhans cell histiocytosis in an adult: case report and literature review. BMC Res Notes BioMed Central. 2016;9(19):1–6.Google Scholar
- Sun J, Zhang J, Lu J, Gao J, Lu T, Ren X, et al. Immunohistochemistry is highly sensitive and specific for detecting the BRAF V600E mutation in papillary thyroid carcinoma. Int J Clin Exp Pathol. 2015;8(11):15072–8.PubMedPubMed CentralGoogle Scholar
- Geissmann F, Lepelletier Y, Fraitag S, Valladeau J, Bodemer C, Debre M, et al. Differentiation of Langerhans cells in Langerhans cell histiocytosis. Blood. 2001;97(5):1241–8.View ArticlePubMedGoogle Scholar
- Murakami I, Matsushita M, Iwasaki T, Kuwamoto S, Kato M, Nagata K, et al. Interleukin-1 loop model for pathogenesis of Langerhans cell histiocytosis. Cell Commun Signal. 2015;13(13):1–15.Google Scholar
- Lee S-H, Yoon H-J. Intralesional infiltration of corticosteroids in the treatment of localized Langerhans cell histiocytosis of the mandible: report of two cases. Oral Surg Oral Med Oral Pathol Oral Radiol Elsevier. 2012;116(4):e255–60.View ArticleGoogle Scholar
- Namai T, Yusa H, Yoshida H. Spontaneous remission of a solitary eosinophilic granuloma of the mandible after biopsy: a case report. J Oral Maxillofac Surg. 2001;59(12):1485–7.View ArticlePubMedGoogle Scholar
- Muscolo D, Slullitel G, Ranalletta M, Aponte-Tinao L, Ayerza M. Spontaneous remission of massive solitary eosinophilic granuloma of the femur. J Pediatr Orthop. 2003;23(6):763–5.View ArticlePubMedGoogle Scholar
- Silva de Paula J, Chahud F, Velasco e Cruz AA. Remissão espontânea de um granuloma eosinofílico orbitário após biópsia: relato de caso e revisão da literatura. Arq Bras Oftalmol. 2003;66(4):523–6.View ArticleGoogle Scholar
- Broadbent V, Pritchard J. Histiocytosis X--current controversies. Arch Dis Child. 1985;60(7):605–7.View ArticlePubMedPubMed CentralGoogle Scholar
- Saunders JG, Eveson JW, Addy M, Bell CN. Langerhans cell histiocytosis presenting as bilateral eosinophilic granulomata in the molar region of the mandible. A case report. J Clin Periodontol. 1998;25(4):340–2.View ArticlePubMedGoogle Scholar
- Altundal H, Salih I, Gürsoy B, Arslan A, Göker K. Spontaneous regression of multifocal eosinophilic granuloma of the mandible : a case report. OHDMBSC. 2003;5(3):36–40.Google Scholar
- McLelland J, Broadbent V, Yeomans E, Malone M, Pritchard J. Langerhans cell histiocytosis: the case for conservative treatment. Arch Dis Child. 1990;65(3):301–3.View ArticlePubMedPubMed CentralGoogle Scholar
- Rimondi E, Mavrogenis AF, Rossi G, Ussia G, Angelini A, Ruggieri P. CT-guided corticosteroid injection for solitary eosinophilic granuloma of the spine. Skeletal Radiol. 2011;40(6):757–64.View ArticlePubMedGoogle Scholar
- Putters TF, de Visscher JG, van Veen A, Spijkervet FK. Intralesional infiltration of corticosteroids in the treatment of localised langerhans’ cell histiocytosis of the mandible. Report of known cases and three new cases. Int J Oral Maxillofac Surg. 2005;34(5):571–5.View ArticlePubMedGoogle Scholar
- Watzke IM, Millesi W, Kermer C, Gisslinger H. Multifocal eosinophilic granuloma of the jaw: Long-term follow-up of a novel intraosseous corticoid treatment for recalcitrant lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;90(3):317–22.View ArticlePubMedGoogle Scholar
- Asaumi J, Konouchi H, Hisatomi M, Matsuzaki H, Kishi K. Two cases of polyostotic eosinophilic granuloma. Dentomaxillofacial Radiol. 2000;29(6):382–5.View ArticleGoogle Scholar